Document is current
Any future updates will be listed below
-
Authors
Beyer, Emillie
Skumlien, Martine
Poudel, Govinda
Arun, Arush Honnedevasthana
McTavish, Eugene
Thomson, Hannah
Sehl, Hannah
Segrave, Rebecca
Clemente, Adam
Labuschagne, Izelle
Rendell, Peter
Terrett, Gill
Manning, Victoria
Suo, Chao
Lorenzetti, Valentina
-
Funding
Funding for this research was provided by:
Research Training Program Stipend scholarships
National Health and Medical Research Council (2016833)
VicHealth
Department of Health, State Government of Victoria
Victorian Responsible Gambling Foundation
National centre for clinical research on emerging drugs
HCF
Philanthropic Organisations
Australian Catholic University competitive scheme
- License Information
-
More Information
Article History
Received: 3 October 2025
Accepted: 24 April 2026
First Online: 5 May 2026
Declarations
:
: Ms Emillie Beyer reports no financial relationships with commercial interests. Dr Martine Skumlien reports no financial relationships with commercial interests. Dr Govinda Poudel is the founder, director and CTO of BrainCast Pty Ltd, which has developed novel brain imaging markers for monitoring brain injury. Arush Honnedevasthana Arun reports no financial relationships with commercial interests. Dr Eugene McTavish reports no financial relationships with commercial interests. Dr Hannah Thomson contracts for Syneos Health Learning Solutions, with the Insights and Evidence Generation Team in Patient Insights and Assessment Research (Implementation Science). Dr Hannah Sehl reports no financial relationships with commercial interests. Dr Rebecca Segrave reports no financial relationships with commercial interests. Dr Adam Clemente reports no financial relationships with commercial interests. Dr Izelle Labuschagne is the founder and director of Complete Thesis Support, which provides developmental programs for research students. Professor Peter Rendell reports no financial relationships with commercial interests. Associate Professor Gill Terrett reports no financial relationships with commercial interests. Dr Victoria Manning was the Founder, CEO, Director and a shareholder of Cognitive Training Solutions Pty Ltd between March 2021 and Aug 2023, which commercialised the SWiPE app, which delivers Cognitive Bias Modification to reduce alcohol use. Dr Chao Suo reports no financial relationships with commercial interests. Professor Valentina Lorenzetti reports no financial relationships with commercial interests.
